CalciMedica, Inc.
Public company- Headquarters
- LA JOLLA, California
- Ticker
- CALC
- CIK
- 0001534133
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOStephen Bardin | Oct 16, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive departure
CFO departs: Stephen Bardin
Stephen Bardin, Chief Financial Officer, principal accounting officer and principal financial officer of CalciMedica, Inc., resigns the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 16, 2026Role: Chief Financial Officer, principal accounting officer and principal financial officer
Only one public record so far. We add events as soon as a new filing lands; watch CalciMedica, Inc. to get them in your digest.
Last verified Nov 8, 2026